Non-Alcoholic Fatty Liver Disease Frequency among Healthy Blood Donors in the West of Iran
Journal Title: Archives of Hepatitis Research - Year 2016, Vol 2, Issue 1
Abstract
Objectives: To investigate the prevalence of NAFLD as well as the determination of associated metabolic abnormalities in Iranian blood donors. The aim of this study was to review cases of non-alcoholic fatty liver disease and to determine the prevalence of non-alcoholic fatty liver disease as a cause of elevated alanine aminotransferase in healthy blood donors and also assess risk factors of NAFLD such as BMI and correlation with metabolic syndrome in these subjects. Background: Non-alcoholic fatty liver disease has been increasingly recognized as the most common pathological conditions affecting the liver. Non-alcoholic fatty liver disease is now recognized as the hepatic component of the metabolic syndrome, which includes hyperlipidemia, glucose intolerance, obesity, and systemic hypertension.
Authors and Affiliations
Mohammad Alizadeh Amir Houshang, Hadizadeh Mohammad, Padashi Maryam, Ranjbar Mitra
Keywords
Related Articles
- EP ID EP559356
- DOI 10.17352/ahr.000004
- Views 56
- Downloads 0
Sarcoidosis-Lymphoma Syndrome presenting by severe Cholestatic Hepatitis
Severe cholestatic hepatitis is an uncommon presentation of either sarcoidosis or Hodgkin lymphoma. Sarcoidosis lymphoma syndrome is a rare disorder with sarcoidosis heralding the onset of lymphoma. Here we report a case...
The Potential of Liver Fibrosis Indexes/Scores for the Screening of Cryptic Liver Fibrosis in Patients with NASH Risk Factors: A Case Report
The unintentional discovery of cirrhosis in a patient with prostate cancer lead us to enquire if some of the indexes/scored designed for the evaluation of liver fibrosis/cirrhosis, in Chronic Hepatitis C patients, could...
Active Navigation in a Hepatitis B Program: Screening, Vaccination and Patient Assistance for Asian Americans in Michigan
Background: Hepatitis B (HBV) is one of the greatest health disparities among Asian Americans. A team of volunteers in Southeast Michigan has studied HBV among Asian Americans in Michigan for 10 years. The study looked a...
Vitamin K: A potential Liver Cancer treatment way
A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K d...
Current Trends of Combination Therapy in Chronic Hepatitis B Management in China
In the past decade, five oral nucleos(t)ide analogs and two formulations of pegylated interferon alpha have been approved for the treatment of chronic hepatitis B (CHB). Due to low personal income and inadequate health c...